Bausch Health Companies Investor Conference Presentation Deck
19
Reconciliation of Reported Revenue to Organic Revenue ¹,2 and
Organic Revenue Growth¹,2 ($M) (Year-to-Date) 4
Calculation of Organic Revenue for the Nine Months Ended
September 30, 2021
September 30, 2020
Bauch +Lomb4
Global Vision Care
Global Surgical
Global Consumerª
Global Ophtho Rx4
Total Bausch + Lomb
Bausch Pharma5
Salix
Salix
International Rx4
International Rx+
Ortho Dermatologics4
Ortho Dermatologics4
Global Solta
Total Ortho Dermatologics
Diversified Products 4
Neurology & Other4
Generics
Dentistry
Total Diversified Products
Total Bausch Pharm a revenues
Total Bausch Health revenues
BAUSCH- Health
Revenue
as
Reported
666
520
1,051
527
2,764
1,515
890
199
219
418
448
127
76
651
Changes in
Exchange
Rates ³
3,474
$ 6,238 $
(14)
(22)
(21)
(12)
(69)
(34)
(9)
(9)
(43)
(112)
$
Organic
Revenue
(Non-
GAAP)¹,2
652
498
1,030
515
2,695
1,515
856
199
210
409
448
127
76
651
3,431
6,126
Revenue
as
Reported
542
394
986
546
2,468
1,377
848
225
166
391
506
176
48
730
Divestitures and
Discontinuations
3,346
$ 5,814 $
(2)
(4)
(1)
(44)
(8)
(52)
(60)
$
Organic
Revenue
(Non-
GAAP) ¹,2
540
390
985
545
2,460
1,377
804
225
166
391
499
175
48
722
3,294
5,754
Change in
Organic Revenue
Amount
112 21%
108
28%
45 5%
(30)
-6%
235 10%
138
52
(26)
44
18
Pct.
137
$ 372
10%
6%
(51)
-10%
(48)
-27%
28 58%
(71) -10%
-12%
27%
5%
4%
6%
1. See Slide 2 and this Appendix for further non-GAAP information
2 Organic growth/change, a non-GAAP metric, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions, divestitures and
discontinuations.
3. The impact for changes in foreign currency exchange rates is determined as the difference in the current period reported revenues at their current period currency exchange rates and the current period reported
revenues revalued using the monthly average currency exchange rates during the comparable prior period.
4. See footnote 3 at slide 6 for further details regarding the realigned segment reporting structure and the conformed prior period presentation.
5. Bausch Pharma revenues, a non-GAAP metric, are determined by subtracting Bausch+Lomb segment revenues for the applicable period from total Bausch Health revenues for the applicable period.View entire presentation